Local anesthetic combination with adjuvants

This page covers all Local anesthetic combination with adjuvants drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Voltage-gated sodium channels (bupivacaine); alpha-2 adrenergic receptors (clonidine); glucocorticoid receptor (dexamethasone).

Targets

Voltage-gated sodium channels (bupivacaine); alpha-2 adrenergic receptors (clonidine); glucocorticoid receptor (dexamethasone)

Phase 2 pipeline (1)

• Bupivacaine, epinephrine, dexamethasone, and clonidine · Tufts Medical Center · Anesthesia/Pain Management
  This combination provides local anesthesia via bupivacaine while epinephrine prolongs duration, dexamethasone reduces inflammation, and clonidine enhances analgesia through alpha-2 adrenergic receptor activation.

Patent intelligence

• local anesthetic combination with adjuvants patent landscape — aggregated cliff calendar, attackable patents, originator estates